Delivery Order SPE2DB24D3015-SPE2DB24FFXKM
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,923.50 firm fixed price delivery order is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty medication. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,472.70 Firm Fixed Price Delivery Order contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,204.67 firm fixed-price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication, with a period of performance through May 9, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,799.95 firm fixed-price delivery order is for the supply of the medication KISQALI 400 MG DAILY DOSE 42S. The contract has an ultimate completion date of February 25, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,045.69, is a delivery order for the supply of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. This award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,716.15 Firm Fixed Price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,988.79 fixed-price delivery order contract is for the provision of KISQALI 400 MG DAILY DOSE 42S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,370.60 Firm Fixed Price Delivery Order covers the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,934.80 firm-fixed-price contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $70,234.60 firm fixed-price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract has an ultimate completion date of May 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...